According to a retrospective cohort study, MACC1 is differentially expressed in CRC and predicts best aggressive clinicopathological features, tumor budding, metastasis formation and poor survival outcome (Koelzer et al., 2015). This evidence concerns the gene MACC1 and colorectal carcinoma.